Researchers uncover a key mechanism that regulates PD-L1, a protein that helps tumors evade the immune system and is the target of several immunotherapy drugs.
Researchers are combining experience in chemical synthesis and nanoparticle engineering with their knowledge of cancer development to design future therapies.